Fortress Biotech, Inc.FBIONASDAQ
Loading
Interest Expense Over TimeStable
Percentile Rank60
3Y CAGR-8.8%
5Y CAGR-7.6%
Studio
Year-over-Year Change

Interest expense on outstanding debt

3Y CAGR
-8.8%/yr
vs +7.2%/yr prior
5Y CAGR
-7.6%/yr
Consistent
Acceleration
-16.0pp
Decelerating
Percentile
P60
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
TTM$10.33M+4.1%
2024$9.93M-20.7%
2023$12.52M-8.2%
2022$13.64M-10.9%
2021$15.31M-0.1%
2020$15.33M+29.3%
2019$11.85M+14.6%
2018$10.34M+34.5%
2017$7.69M+108.3%
2016$3.69M-